Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds—Histamine H3 Receptor Ligands and MAO-B Inhibitors
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27020581 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Dorota Łażewska und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-…. Hauptthemen laut MEDLINE: Monoamine Oxidase Inhibitors, Chalcones, Monoamine Oxidase, Receptors, Histamine H3. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Priority Research Area qLIFE under the Strategic Programme Excellence Initiative at Jagiellonian University, Jagiellonian University Medical College in Kraków, Statutory activity of Medical University of Lodz.
Abstract (Originalsprache)
Chalcone-based derivatives were designed as dual-acting ligands targeting the histamine H3 receptor (H3R) and monoamine oxidase B (MAO-B), based on the lead compound DL76. Three series of compounds (1–18) were synthesised and characterised, including simple chalcones (1–9) and piperidinyl chalcones (10–18). All piperidinyl derivatives exhibited nanomolar affinity for human H3R (hH3R), with compounds 10–12 achieving Ki values ≤ 30 nM. Simple chalcones showed potent human MAO-B (hMAO-B) inhibition (IC50: 0.85–337 nM), especially 3,4-dichloro derivatives. Compound 15 was the most active hybrid, with a Ki of 46.8 nM for hH3R and an IC50 of 212.5 nM for hMAO-B. Molecular docking and 250 ns simulations revealed stabilising interactions at both binding sites and clarified structural features behind dual activity. Preliminary ADMET profiling showed low Caco-2 permeability and rapid microsomal metabolism, mainly via hydroxylation. Compound 15 exhibited micromolar cytotoxicity in SH-SY5Y and HepG2 cells, induced G2/M arrest, disrupted mitochondrial homeostasis, and was genotoxic in Peripheral Blood Mononuclear Cells (PBMCs). Additionally, for H3R ligands (15, DL76, pitolisant), the study reports the first use of Surface Plasmon Resonance Microscopy (SPRM) to assess their interactions with this receptor. Therefore, piperidinyl chalcones show promise as ligands with dual action on H3R and MAO-B, useful in the treatment of neurodegeneration and/or CNS cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.
- Department of Pharmacobiology, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.
- Radioisotope and Functional Analysis Laboratory, Center for the Development of Therapies for Civilization and Age-Related Diseases, Jagiellonian University Medical College in Kraków, Medyczna 7A, 30-688 Kraków, Poland.
- Department of Hormone Biochemistry, Faculty of Medicine, Medical University of Łódź, Żeligowskiego 7/9, 90-752 Łódź, Poland.
- Laboratory of Cellular Immunology, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Łódź, Poland.
- Pharmacokinetics and Preliminary Toxicological Analysis Laboratory, Center for the Development of Therapies for Civilization and Age-Related Diseases, Jagiellonian University Medical College in Kraków, Medyczna 7A, 30-6…
ORCID-Profile: Dorota Łażewska, Kamil Kuder, Waldemar Wagner, Agnieszka Olejarz-Maciej, Katarzyna Woźniak, Gniewomir Latacz, Anna Stasiak
Förderung
- the Priority Research Area qLIFE under the Strategic Programme Excellence Initiative at Jagiellonian University
- Jagiellonian University Medical College in Kraków
- Statutory activity of Medical University of Lodz
- Priority Research Area qLIFE under the Strategic Programme Excellence Initiative at Jagiellonian University
- Statutory activity of Medical University of Lodz, Poland
Zitieren
APA
Łażewska, D., Doroz-Płonka, A., Kuder, K., Siwek, A., Wagner, W., Karnafał-Ziembla, J., Olejarz-Maciej, A., Wolak, M., Głuch-Lutwin, M., Mordyl, B., Osiecka, O., Juszczak, M., Woźniak, K., Więcek, M., Latacz, G., & Stasiak, A. (2026). Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds—Histamine H3 Receptor Ligands and MAO-B Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020581
Vancouver
Łażewska D, Doroz-Płonka A, Kuder K, Siwek A, Wagner W, Karnafał-Ziembla J, et al. Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds—Histamine H3 Receptor Ligands and MAO-B Inhibitors. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020581
BibTeX
@article{aewska2026,
author = {Łażewska, Dorota and Doroz-Płonka, Agata and Kuder, Kamil and Siwek, Agata and Wagner, Waldemar and Karnafał-Ziembla, Joanna and Olejarz-Maciej, Agnieszka and Wolak, Małgorzata and Głuch-Lutwin, Monika and Mordyl, Barbara and Osiecka, Oktawia and Juszczak, Michał and Woźniak, Katarzyna and Więcek, Małgorzata and Latacz, Gniewomir and Stasiak, Anna},
title = {Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds—Histamine H3 Receptor Ligands and MAO-B Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27020581}
}
EUVIMED